Cargando…
Successful treatment with DCF chemotherapy and radiotherapy for primary squamous cell carcinoma of the prostate
INTRODUCTION: Primary squamous cell carcinoma of the prostate is an extremely rare tumor with poor prognosis. Squamous cell carcinoma of the prostate is estimated to comprise less than 1% of all prostate carcinomas. We report herein a case with clinical response to docetaxel, cisplatin, and 5‐fluoro...
Autores principales: | Atagi, Kaya, Fukuhara, Hideo, Ishiguro, Motoyoshi, Osakabe, Hiroto, Satoshi, Fukata, Tamura, Kenji, Karashima, Takashi, Inoue, Keiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560450/ https://www.ncbi.nlm.nih.gov/pubmed/34755073 http://dx.doi.org/10.1002/iju5.12365 |
Ejemplares similares
-
Synchronous bilateral renal cell carcinomas with differing histologies
por: Shigehisa, Ryu, et al.
Publicado: (2020) -
Evaluation of a rapid one-step PSA test for primary prostate cancer screening
por: Ashida, Shingo, et al.
Publicado: (2021) -
Primary adrenal Ewing’s sarcoma family of tumors with tumor thrombus of the inferior vena cava: a case report
por: Atagi, Kaya, et al.
Publicado: (2023) -
Combination with third-generation bisphosphonate (YM529) and interferon-alpha can inhibit the progression of established bone renal cell carcinoma
por: Kurabayashi, Atsushi, et al.
Publicado: (2015) -
Vibegron 50 mg Once Daily Improves OABSS, OAB-q SF Score in OAB Patients ≥80 Years Old in Real-World Clinical Settings and Switching from Other OAB Drugs May Reduce Residual Urine Volume
por: Kuno, Takahira, et al.
Publicado: (2023)